
Plymouth, Minnesota, United States
Endogenex is a clinical-stage medical device company that aims to revolutionize treatment options for individuals with type 2 diabetes (T2D) in partnership with Mayo Clinic. It focuses on developing an endoscopic procedure to help patients regain control of their blood glucose levels.
- Revenue
- $9.5M
- Customers
- -
- Year founded
- 2017
- Funding
- -
- Team size
- 25
- Growth
- -